Cenicriviroc and Impurities
Cenicriviroc
CAS:497223-25-3
Formula:
C41H52N4O4S
Color and Shape:
Pale Yellow Solid
Molecular weight:
696.96
Ref: 4Z-C-159001
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 May 2024
Ref: 4Z-C-159004
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Friday 17 May 2024
Ref: 4Z-C-159003
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Friday 17 May 2024
Ref: 4Z-C-159002
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Friday 17 May 2024
Cenicriviroc
CAS:497223-25-3
Cenicriviroc (TAK-652) is an orally active, dual antagonist of CCR2/CCR5. It also inhibits both HIV-1 …
Formula:
C41H52N4O4S
Purity:
98.98%
Color and Shape:
Solid
Molecular weight:
696.94
Ref: TM-TQ0297
| 1mg | 68.00 € | |
| 2mg | 87.00 € | |
| 5mg | 124.00 € | |
| 10mg | 191.00 € | |
| 25mg | 383.00 € | |
| 50mg | 496.00 € | |
| 100mg | 713.00 € | |
| 200mg | 1,007.00 € | |
| 1ml*10 (DMSO) | 206.00 € |
Estimated delivery in United States, on Friday 17 May 2024
